Korean Post-marketing Surveillance for Xeljanz XR
Conditions
Active Moderate to Severe Rheumatoid Arthritis · Active Ankylosing Spondylitis · Active Psoriatic Arthritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Pfizer, Seoul, South Korea
Study leads
Pfizer CT.gov Call Center
Study Director
Pfizer